Inherited retinal diseases affect millions of people worldwide. For decades, Michael Kalloniatis has worked at the forefront of research, education and clinical care to better understand these conditions and improve outcomes for patients.

This month, Retina Australia, a member of Retina International, recognized Kalloniatis as the first recipient of its newly established Hall of Fame Award. The honor celebrates individuals who have made lasting contributions nationally or internationally to improve the lives of those affected by inherited retinal diseases.

“I am deeply honored and humbled to be the inaugural recipient of the Retina Australia Hall of Fame Award,” Kalloniatis said. “This recognition is a personal milestone and a reflection of the many individuals who have worked alongside me in the laboratory and in the clinic. I share this honor with colleagues, past and present students, and postdoctoral fellows.”

Kalloniatis began his research journey with a $6,000 grant from Retina Australia in 1992. That early support led to larger, nationally competitive grants from the Australian National Health and Medical Research Council and the New Zealand Health Research Council, enabling him to train a new generation of Ph.D. students and postdoctoral fellows. Many of those he mentored now lead their own laboratories, advancing retinal research around the world.

His career has spanned institutions including the University of Melbourne, the University of Auckland, the University of New South Wales, Deakin University and University of Houston. Now based in Houston, Kalloniatis continues to contribute to discoveries that advance patient care not only in Australia, but also in the United States and globally.

“I am thankful to Retina Australia for this recognition and wish the organization continued success in supporting vision and retinal research,” he said.